Rapid, simultaneous detection of respiratory pathogens<\/p>\n
The Respiratory Multiplex Array is intended for the simultaneous detection of 22 bacterial and viral respiratory pathogens in individuals suspected of Respiratory Tract Infections. The ability to simultaneously detect these in one sample provides clinicians with a complete patient profile, enabling faster and more appropriate treatment decisions. <\/p>\n
The Respiratory Multiplex Array is based on a combination of multiplex PCR, biochip hybridization and chemiluminescence detection using the Evidence Investigator analyser. The array can run 54 samples simultaneously in five hours. Identifying multiple pathogens will provide a rapid and more cost-effective diagnostic tool than current methods – which only look for single pathogens – thus reducing the time from presentation to treatment and minimizing sample requirements. Save time and costs associated with single pathogen detection by using the Respiratory Multiplex Array.<\/p>\n
Website: http:\/\/www.randox.com\/respiratory-molecular-test.php<\/link>\n
Email: marketing@randox.com<\/link>\n
\nSupplier:<\/strong> Randox Laboratories Ltd.
\nWebsite:<\/strong> <\/a><\/p>\n